Global Bioreactors and Fermenters Market: Snapshot
Bioreactors and fermenters are used for creating proper environment for the growth of microorganisms or driving biochemically active substances derived from such organisms. Fermenters are basically utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. Bioreactors, the large sized fermenters, are widely used in biopharmaceutical industry for the production of biologics such as monoclonal antibodies, recombinant proteins, and vaccines at a large scale.
In the past few years, the process of large-scale bio-manufacturing has become more practical owing to advancements in technology and the easy availability of machines large enough to produce significantly high volumes of biologics due to progress in expression systems, cell lines, and cultures. These advancements have boosted the requirement for equipment as demand for small volume and multi-product capabilities have enabled facilities to adjust unit operations based on demand without incurring wastages and additional expenses.
According to Transparency Market Research, the global bioreactors and fermenters market is projected to reach US$4461.0 mn in 2024 at a CAGR of 12.2% from 2016 to 2024.
Single-use Bioreactors to Witness Increased Adoption
In terms of product type, the market for bioreactors and fermenters has been segmented in the report into single-use bioreactors and multiple-use bioreactors. Of these, the segment of single-use bioreactors are gaining more popularity than multiple-use bioreactors as the former ones offer benefits such as lower capital expenditure, smaller footprint, quick assembly, and reduction in the risk of cross contamination. Demand for single-use bioreactors is expected to further rise as cost pressures from the health care providers increase and new markets open. This would require a level of flexibility and speed in construction, which is not possible with conventional bioreactors.
However, the segment of multiple-use bioreactors is presently the leading contributor of revenue to the global market, accounting for a massive 59% of the overall market in 2016. The well-established segment will continue to lead the global market and grow at a promising pace, albeit at a lower growth rate as compared to the segment of single-use bioreactors.
Asia Pacific Market to Steer Ahead at Promising Growth Rate
From a geographical standpoint, developed regions North America and Europe commanded a clear dominance in the global bioreactors and fermenters market in2015, collectively accounting for a nearly 62% of the global market.
North America led the market in the said year, a feat chiefly attributable to the vast technological advancements achieved in the field of bioprocessing systems and the increased adoption of single-use disposable bioreactors. The North America marker for bioreactors and fermenters also has a strong hold on the global market owing to the presence of several biopharmaceutical companies and bioprocessing equipment manufacturers. Native companies such as Thermo Fischer Scientific Inc, GE Healthcare and Danaher Corporation have fuelled the demand for the bioreactors and fermenters in the region and are considered to keep the demand for bioreactors and fermenters strong in the next few years.
Over the report’s forecast period, however, the Asia Pacific market for bioreactors and fermenters is expected to be the market with the most promising growth rate. With several factors working in its favor, such as strengthening economies and funds being poured in by international biopharmaceutical companies and contract manufacturers aiming to exploit the vast growth opportunities that the region has to offer, the Asia Pacific market is likely to register a 14.3% CAGR from 2016 to 2024. The rising prevalence of chronic diseases and the resultant rise in demand for biologics are also driving the market for bioreactors and fermenters in Asia Pacific.
Some of the leading players operational in the global market for bioreactors and fermenters are Finesse Solutions, Inc., Applikon Biotechnology B.V., PBS Biotech, Inc., Danaher Corporation, Sartorius AG, Eppendorf AG, ZETA Holding GmbH, GE Healthcare, Solaris Biotechnology srl, PIERRE GUERIN TECHNOLOGIES, Thermo Fisher Scientific Inc and Merck KGaA. Popular business growth strategies employed by players in the market include strategic acquisitions and collaborations and other activities aimed at expanding their global footprint.
Global Bioreactors and Fermenters Market: Overview
Bioreactors and fermenters are mainly used in research institutes and bioprocessing industries. Bioreactors are employed for the cultivation of mammalian, plants, and insect cells, and for large scale production of pharmaceuticals, antibodies, vaccines, etc., or for the bioconversion of organic wastes. Fermenters are utilized for the growth and maintenance of a population of bacterial or fungal cells in a controlled mode. They are small as compared to bioreactors. This report analyzes the current and future prospects of the bioreactors and fermenters market based on product, process, end user and geography.
Global Bioreactors and Fermenters Market: Scope of the Report
The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of bioreactors used in biopharmaceutical industries, CROs, etc. in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases. The report provides estimated market size in terms of US$ Mn for product, process, end user, and geography for the period 2015 to 2024. The revenue generated from product type was calculated by considering the adoption rate of bioreactors and fermenters across all geographies, number of product launched, average cost of products, trends in industry, and end user trends, among others.
Global Bioreactors and Fermenters Market: Segmentation
The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product, process, end user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the bioreactors and fermenters market in the current and future scenario. The report also provides value chain analysis of the market that describes the sequence of activities involved, from identification of the market need to their final reach to the end users. Furthermore, the report provides Porter’s five force analysis that studies five factors and their impact on the bioreactors and fermenters market.
Global Bioreactors and Fermenters Market: Competitive Analysis
Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis contributing majorly in the bioreactors and fermenters market.
The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the bioreactors and fermenters market include Applikon Biotechnology B.V., Danaher Corporation, Eppendorf AG, Finesse Solutions, Inc., GE Healthcare, Merck KGaA, PBS Biotech, Inc., PIERRE GUERIN TECHNOLOGIES, Sartorius AG, SOLARIS BIOTECHNOLOGY srl, Thermo Fisher Scientific Inc and ZETA Holding GmbH. Acquisitions was the primary strategy adopted by the major market players to enter into the bioreactors and fermenters market. For instance, GE Healthcare acquired Xcellerex, Inc. in 2012, to establish its footprints in single-use bioreactors market.
The Bioreactors and Fermenters Market has been segmented as follows:
- Bioreactors and Fermenters Market, by Product, Revenue (US$ Mn) 2016-2024
- Single-use Bioreactors
- Multiple-use Bioreactors
- Bioreactors and Fermenters Market, by Process, Revenue (US$ Mn) 2016-2024
- Fed batch
- Bioreactors and Fermenters Market, by End User, Revenue (US$ Mn) 2016-2024
- Biopharmaceutical companies
- Academic & Research Institutes
- Bioreactors and Fermenters Market, by Geography, Revenue (US$ Mn), 2016-2024
- North America
- Rest of Europe
- Latin America
- Rest of Latin America
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
- North America